Author:
Doyle Carolyn A.,McDougle Christopher J.
Publisher
Springer International Publishing
Reference24 articles.
1. Abbott, A. (2007). Neuroscience: The molecular wake-up call. Nature, 447(7143), 368–370.
2. Anderson, B. M., Schnetz-Boutaud, N., et al. (2008). Examination of association to autism of common genetic variation in genes related to dopamine. Autism Research, 1(6), 364–369.
3. Baskerville, T. A., & Douglas, A. J. (2010). Dopamine and oxytocin interactions underlying behaviors: Potential contributions to behavioral disorders. CNS Neuroscience and Therapeutics, 16(3), e92–e123.
4. Birkmayer, W., & Hornykiewicz, O. (1961). The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia. Wiener Klinische Wochenschrift, 73, 787–788.
5. Correia, C. T., Almeida, J. P., et al. (2010). Pharmacogenetics of risperidone therapy in autism: Association analysis of eight candidate genes with drug efficacy and adverse drug reactions. The Pharmacogenomics Journal, 10(5), 418–430.